FDA Inspection 1118178 - New York Blood Center Enterprises - February 11, 2020

Record Details

This FDA Inspection record concerns New York Blood Center Enterprises, with an inspection on February 11, 2020, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company: New York Blood Center Enterprises
Inspection Date: February 11, 2020
Product Type: Biologics
Office: Center for Biologics Evaluation and Research

Open in Dashboard

ID · d7c05152-a755-44b7-acb6-8b9840cbb679

Violation Codes4

21 CFR 1271.75(a)(1)21 CFR 211.160(a)21 CFR 211.160(b)21 CFR 211.192

Full citation text and observation details available on the Dashboard.